Oral treatment
Eli Lilly Enters Second Collaboration with Nimbus Therapeutics in $55M Upfront Deal for Novel Oral Obesity Drug
Eli Lilly; Nimbus Therapeutics; obesity drug; $55M upfront; $1.3B deal; oral treatment; metabolic diseases
FDA approves new gonorrhea antibiotics from GSK and Innoviva
gonorrhea; antibiotic resistance; GSK; Blujepa; gepotidacin; Innoviva; Nuzolvence; zoliflodacin; FDA approval; uncomplicated urogenital gonorrhea; first-in-class antibiotic; oral treatment
Nuvation Bio Scores First FDA Approval for Oral Lung Cancer Drug Ibtrozi
Nuvation Bio; FDA approval; Ibtrozi; taletrectinib; lung cancer; ROS1-positive NSCLC; oral treatment; tyrosine kinase inhibitor
FDA Approves Evrysdi Tablets: A Breakthrough in Convenient SMA Treatment
Evrysdi, risdiplam, spinal muscular atrophy (SMA), FDA approval, tablet formulation, oral treatment, Genentech, Roche
Revolutionary Oral Treatment for Retinal Disease Shows Promising Results in Phase II Trials
Retinal disease, oral treatment, Phase II trials, revolutionary, promising results, Rezolutes.
Crinetics’ Paltusotine Demonstrates Success in Second Phase III Trial for Oral Acromegaly Treatment, Prepares for FDA Filing
Crinetics Pharmaceuticals, Paltusotine, Acromegaly, Phase III trials, FDA submission, Oral treatment, Symptom reduction